• Program
  • Registration
  • Venue
  • Accommodation
  • banner

  • Program
    Ēš DOWNLOAD program afile
    Program at a Glance
    09:00-09:20 Registration
    09:20-11:00 Session 1. Personalized Medicine for Tuberculosis Therapy
    11:00-11:20 Coffee Break
    11:20-12:20 Opening Ceremony
    12:20-13:20 Lunch Break
    13:20-15:00 Session 2. The Model Based Approach for Personalized Therapy of Tuberculosis
    15:00-15:20 Coffee Break
    15:20-17:30 Session 3. Korea as a Potential Leading R&D Country of Tuberculosis Eradication
    17:30-18:00 Panel Discussion
    18:00-18:10 Closing Remarks
    Program Details
    09:00-09:20
    Registration


    09:20-13:20
    Session 1: Personalized Medicine for Tuberculosis Therapy
    Co-Chair : Sung Soon Lee, Inje University Ilsan Paik Hospital
                  Hyun-kyung Lee, Inje University Busan Paik Hospital

    [09:20-10:00] Personalized therapy in MDR-TB
    Jan Heyckendorf (Research Center Borstel, Germany)

    [10:00-10:30] Pharmacogenomics of antituberculosis drugs
    Rika Yuliwulandari (Yarsi University, Indonesia)

    [10:30-11:00] Application of PBPK modeling and simulation for personalized precision dosing of ethambutol
    Md Masud Parvez (Inje University College of Medicine, Korea)

    [11:00-11:20] Coffee Break

    11:20-12:20
    Opening Ceremony : Welcome / Congratulatory Remark
    Introduction of Center for Personalized Medicine of Tuberculosis: Jae-Gook Shin (Director, cPMTb,Inje University College of Medicine, Korea)

    12:20-13:20
    Luncheon

    13:20-15:20
    Session 2: The Model Based Approach for Personalized Therapy of Tuberculosis
    Co-Chair : Ho Kee Yum, Inje University Seoul Paik Hospital
                  Dong Hyun Kim, Inje University College of Medicine

    [13:20-14:00] Personalized dosing and personalized duration of therapy in TB
    Tawanda Gumbo (Baylor Research Institute, USA)

    [14:00-14:30] Population pharmacokinetics of antituberculosis drugs for personalized dosing
    Jong-Lyul Ghim (Inje University Busan Paik Hospital, Korea)

    [14:30-15:00] Application of physiologically based pharmacokinetic modeling to manage the adverse events in multiple drug resistant patients in Vietnam
    Nguyen Thi Thu Phuong (Hai Phong University of Medicine and Pharmacy, Vietnam)

    [15:00-15:20] Coffee Break

    15:20-17:30
    Session 3: Korea as a Potential Leading R&D Country of Tuberculosis Eradication
    Co-Chair : Chul Hun Chang, Pusan National University Hospital
                  Jin Ho Chun, Inje University College of Medicine

    [15:20-16:00] Oxazolidinones for TB treatment; past, present and future
    Clifton E. Barry III (National Institutes of Health, USA)

    [16:00-16:30] Optimal regimens and drug dosing for M. avium complex pulmonary disease
    Won-Jung Koh (Samsung Medical Center, Korea)

    [16:30-17:00] Tuberculosis situation in North Korea and prospect for TB transition in the Korean peninsula after peace regime
    Kyung Hyun Oh (Korean Institute of Tuberculosis, Korea)

    [17:00-17:30] Autophagy : a new strategy for host-directed therapy of tuberculosis
    Eun-Kyeong Jo (Chungnam National University College of Medicine, Korea)

    17:30-18:00
    Panel Discussion : Why, What, How we can do?
    Chair : Jae-Gook Shin, Inje University College of Medicine

    Panelist
    Young Lag Cho (LegoChem Biosciences, Inc., Korea)
    Dae Yeon Kim (Masan National Tuberculosis Hospital, Korea)
    Jeongha Mok (Pusan National University Hospital, Korea)
    In-Sik Kong (Korea Centers for Disease Control and Prevention, Korea)


    18:00-18:10
    Closing Remarks


  • Copyright Center for Personalised Precision Medicine of Tuberculosis, Inje University College of Medicine, Korea
    kim8745698@inje.ac.kr or Tel to: 82-51-890-6412